Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piperacillin/Tazobactam PK/PD in Early Severe Sepsis
NCT02730624Phase 4Completed
- Start
- Mar 2014
- Primary completion
- May 2016
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of piperacillin + tazobactam in sepsis, septic shock. Started Mar 2014; status: completed.
02
Drugs
piperacillin + tazobactam
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT02730624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02730624.